Most Recent Additions*


Conference Program
Amine Kamen, Tarit Mukhopadhyay, Charles Lutsch, and Nathalie Garçon


Virus-like particle vaccines against BK and JC polyomaviruses
Diana V. Pastrana, Alberto Peretti, Eileen M. Geoghegan, and Christopher B. Buck


Molecular quality engineering for low cost vaccine production
Kerry Routenberg Love, Neil C. Dalvie, J. Christopher Love, and Joseph R. Brady


Single-cell analysis uncovers a novel influenza A virus-derived defective interfering particle for antiviral therapy
Sascha Young Kupke, Dietmar Riedel, Timo Frensing, Pawel Zmora, and Udo Reichl


Persistent antibody clonotypes dominate the serum response to influenza following repeated vaccination over multiple years
Jiwon Lee; Andrew P. Horton; Jonathan R. McDaniel; Daniel R. Boutz; Jiwon Jung; Dania A. Hussein; Gregory C. Ippolito; George Georgiou; Philipp Paparoditis,; Alexander Frühwirth; Leontios Pappas; Davide Corti; and Antonio Lanzavecchia


Pan-HA antibodies confer protection in mice against influenza
Aziza Manceur, Wangxue Chen, Amalia Ponce, Anne Marcil, Wei Zou, Gilles St-Laurent, Yves Durocher, Mélanie Leclerc, Parminder Chahal, Sven Ansorge, Marie-Hélène Venne, Viktoria Lytvyn, and Rénald Gilbert


Accelerating bioprocess development by analysis of all available data: A USP case study
Diego Suarez-Zuluaga, Nicole Driessen, Yvonne Thomassen, Wilfried Bakker, and Daniel Borchert


Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates
Pavel Marichal-Gallardo, A. Raquel Fortuna, Yvonne Genzel, Michael Wolff, and Udo Reichl


Bioprocess intensification for production of a Peste des petits ruminants virus (PPRV) vaccine
Manuel J.T. Carrondo, Marcos Sousa, Gerhard Greller, Christel Fenge, Jens Rupprecht, and Alexander Tappe


Continuous purification of cell culture-derived influenza A virus particles through pseudo- affinity membrane chromatography
A. Raquel Fortuna, Florian Taft, Louis Villain, Michael W. Wolff, and Udo Reichl


Integrated scalable cyto-technology for recombinant protein bioprocessing
J. Christopher Love, Amos Lu, Kerry R. Love, and Laura Crowell


Low-cost cell-based production platform for seasonal and pandemic influenza vaccines
Alan Yung-Chih Hu, Tsai-Chuan Weng, Jenny Bang, and Jessie H.-T. Ni

*Updated as of 09/20/18.